药品分销市场规模、份额和增长分析：按产品类型、治疗领域、分发类型、无菌性别、年龄组、分销渠道和地区划分 - 2026-2033 年行业预测

预计到 2024 年，全球配药药局市场规模将达到 160.8 亿美元，到 2025 年将成长至 170.1 亿美元，到 2033 年将成长至 267.1 亿美元，在预测期（2026-2033 年）内复合年增长率为 5.8%。

受专利到期、人口老化和预期寿命延长等因素的推动，全球配製药房市场预计将持续成长。配製药房专注于根据患者的个别需求定製药物，生产传统製药公司难以提供的独特配製药物。这些由持证专业人员配製的个人化药物剂型多样，包括调味液体、外用乳霜和凝胶，确保治疗方案符合每位患者的特定需求。该市场主要面向成年人，提供营养补充品并治疗由生活方式因素引起的慢性疾病。不良饮食习惯和久坐不动的生活方式导致慢性疾病日益普遍，预计将进一步增加对专业配製药物的需求，从而推动市场成长。

推动全球配药药房市场发展的因素

全球配製药房市场预计将迎来显着成长，主要受口服药物（如片剂和胶囊）日益普及的偏好。这一趋势反映了口服药物的广泛接受度，尤其是在许多疾病只能透过口服给药有效控制的情况下。随着患者寻求便捷可靠的治疗方案，对客製化口服药物的需求持续增长，从而推动了市场扩张。医疗保健格局的不断变化和创新口服製剂的研发进一步巩固了这一上升趋势，凸显了口服药物在现代医学中的重要作用。

全球药局市场面临的限制因素

由于某些药品监管日益严格，全球配药局市场面临严峻挑战。监管机构正在实施限制某些药物配製的措施，这影响了这些复杂药物製剂的销售。随着禁令扩展到常用药物，对常用配製药品的需求可能会下降，导致配製药房的市场机会萎缩。这种变化为製药企业和药剂师带来了不确定性，他们必须在应对合规复杂性的同时，适应不断变化的法规和消费者需求，并在日益严格的环境下维持永续的产品供应。

全球药局市场趋势

全球配製药市场正经历强劲成长，这主要得益于研发投入的激增，尤其是针对凝胶、乳膏和软膏等创新型外用製剂的研发。在对个人化药物和以患者为中心的解决方案日益增长的需求推动下，製药公司正投入大量资源开发独特且客製化的产品，以满足特定的医疗需求。这一趋势反映了医疗服务向个人化医疗的转变，以及人们对配製药益处的认识不断提高。随着医疗服务提供者和患者寻求更有效的治疗方案，预计配製药市场将继续扩张，并充分利用製剂技术和个人化医疗的进步。

目录

介绍

• 调查目标
• 市场定义和范围

调查方法

• 调查过程
• 二手资料和一手资料方法
• 市场规模估算方法
• 市场假设与限制

执行摘要

• 全球市场展望
• 主要市场亮点
• 细分市场概览
• 竞赛概况

市场动态与展望

• 总体经济指标
• 驱动因素和机会
• 限制与挑战
• 供给面趋势
• 需求面趋势
• 波特的分析和影响

关键市场考察

• 关键成功因素
• 影响市场的因素
• 关键投资机会
• 生态系测绘
• 市场吸引力指数（2025）
• PESTEL 分析
• 价值链分析
• 客户和购买标准分析
• 案例研究
• 监管环境
• 专利分析

全球配药药房市场规模（按产品类型划分）（2019-2032 年）

• 口服
  • 胶囊
  • 药片
  • 混合物
  • 棒糖
  • 锭剂
• 外用药物
  • 凝胶
  • 软膏
  • 奶油
  • 洗剂
• 直肠
• 鼻腔
• 眼科
• 其他的

全球药品分销市场按治疗领域划分（2019-2032 年）

• 荷尔蒙补充疗法
• 疼痛管理
• 皮肤科
• 营养补充品
• 减重
• 其他的

全球按配药类型分類的配药药房市场规模（2019-2032 年）

• 药品成分变更（PIA）
• 目前无法使用的药品生产（CUPM）
• 药物剂量调整（PDA）
• 其他的

全球药局市场规模（依无菌类型划分）（2019-2032 年）

• 无菌
• 非无菌

全球药局市场按年龄层划分（2019-2032 年）

• 儿童
• 成人版
• 老年人

全球药品分销通路市场（2019-2032 年）

• 在线的
• 离线
  • 配药药房
  • 医院药房
  • 其他的

全球配药药房市场规模（按地区划分）（2019-2032 年）

• 北美（依产品类型、治疗领域、製剂类型、无菌性别、年龄层、通路划分）
  • 美国
  • 加拿大
• 欧洲（依产品类型、治疗领域、製剂类型、无菌性别、年龄层、通路划分）
  • 英国
  • 德国
  • 西班牙
  • 法国
  • 义大利
  • 其他欧洲地区
• 亚太地区（依产品类型、治疗领域、製剂类型、无菌性别、年龄层及通路划分）
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲（依产品类型、治疗领域、製剂类型、无菌性别、年龄层、通路划分）
  • 巴西
  • 墨西哥
  • 其他拉丁美洲地区
• 中东和非洲（按产品类型、治疗领域、製剂类型、无菌性别、年龄层和分销管道划分）
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争对手仪錶板

• 前五大公司对比
• 主要企业的市场定位（2025 年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市占率分析（2025 年）

主要企业简介

• Becton, Dickinson and Company
• B. Braun Melsungen AG
• Fagron NV
• Fresenius Kabi AG
• McGuff Compounding Pharmacy Services Inc.
• Village Compounding Pharmacy
• Dougherty's Pharmacy, Inc.
• Institutional Pharmacy Solutions
• Walgreen Co.
• Triangle Compounding Pharmacy
• Custom Med Apothecary
• Olympia Pharmacy
• Precision Compounding Pharmacy
• College Pharmacy
• Rx3 Compounding Pharmacy
• Aurora Health Care
• Wedgewood Pharmacy
• Afrigen Biologics
• Albertsons Companies
• Formul8

结论和分析师建议

Global Compounding Pharmacy Market size was valued at USD 16.08 Billion in 2024 and is poised to grow from USD 17.01 Billion in 2025 to USD 26.71 Billion by 2033, growing at a CAGR of 5.8% during the forecast period (2026-2033).

The Global Compounding Pharmacy Market is poised for growth, driven by factors such as patent expirations, an aging population, and increased life expectancy. Compounding pharmacies specialize in tailoring medications to meet individual patient needs, creating unique formulations that are often unavailable from traditional pharmaceutical companies. These personalized medications, crafted by licensed professionals, can take various forms including flavored liquids, topical creams, and gels, ensuring that treatment aligns with specific patient requirements. The market predominantly serves adults, offering nutritional supplements and addressing chronic conditions that arise from lifestyle choices. As chronic diseases become more prevalent, further fueled by poor dietary habits and sedentary lifestyles, the demand for specialized compounded medications is set to rise, propelling the market forward.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Compounding Pharmacy market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Compounding Pharmacy Market Segments Analysis

Global Compounding Pharmacy Market is segmented by Product Type, Therapeutic Area, Compounding Type, Sterility, Age Cohort, Distribution Channel and region. Based on Product Type, the market is segmented into Oral, Topical, Rectal, Nasal, Ophthalmic and Others. Based on Therapeutic Area, the market is segmented into Hormone replacement therapy, Pain management, Dermatology, Nutritional Supplements, Weight Loss and Others. Based on Compounding Type, the market is segmented into Pharmaceutical Ingredient Alteration (PIA), Currently Unavailable Pharmaceutical Manufacturing (CUPM), Pharmaceutical Dosage Alteration (PDA) and Others. Based on Sterility, the market is segmented into Sterile and Non Sterile. Based on Age Cohort, the market is segmented into Pediatric, Adult and Geriatric. Based on Distribution Channel, the market is segmented into Online and Offline. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Compounding Pharmacy Market

The Global Compounding Pharmacy market is expected to experience significant growth, fueled by the increasing preference for oral medications such as tablets and capsules. This trend reflects the broader acceptance of oral pharmaceuticals, particularly since many medical conditions can only be effectively managed through oral administration. As patients seek convenient and reliable treatment options, the demand for customized oral medications continues to rise, contributing to the expansion of the market. The evolving landscape of healthcare and the ongoing development of innovative oral formulations further support this upward trajectory, highlighting the pivotal role of oral pharmaceuticals in modern medical treatment.

Restraints in the Global Compounding Pharmacy Market

The global compounding pharmacy market faces significant challenges due to increasing restrictions on certain pharmaceuticals. Regulatory authorities have implemented measures that limit the compounding of specific medications, impacting the sales potential of these complex drug formulations. As prohibitions expand to include commonly used drugs, the demand for popular compounded medications may diminish, resulting in a decline in market opportunities for compounding pharmacies. This evolving landscape creates uncertainties for pharmaceutical manufacturers and pharmacists, who must adapt to changing regulations and consumer needs while navigating the complexities of compliance and maintaining a viable product offering in an increasingly restrictive environment.

Market Trends of the Global Compounding Pharmacy Market

The global compounding pharmacy market is experiencing robust growth driven by a surge in research and development focused on innovative topical formulations such as gels, creams, and ointments. With an increasing demand for personalized medication and patient-centric solutions, pharmaceutical companies are dedicating significant resources to develop unique and tailored products that address specific healthcare needs. This trend reflects a broader shift towards individualized treatments and the rising awareness of the benefits of compounded medications. As healthcare providers and patients alike seek more effective therapeutic options, the compounding pharmacy market is poised for continued expansion, leveraging advancements in formulation technology and personalized care.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Value Chain Analysis
• Customer & Buying Criteria Analysis
• Case Studies
• Regulatory Landscape
• Patent Analysis

Global Compounding Pharmacy Market Size By Product Type (2019-2032)

• Market Overview
• Oral
  • Capsule
  • Tablets
  • Mixtures
  • Lollipops
  • Lozenges
• Topical
  • Gels
  • Ointments
  • Cream
  • Lotions
• Rectal
• Nasal
• Ophthalmic
• Others

Global Compounding Pharmacy Market Size By Therapeutic Area (2019-2032)

• Market Overview
• Hormone replacement therapy
• Pain management
• Dermatology
• Nutritional Supplements
• Weight Loss
• Others

Global Compounding Pharmacy Market Size By Compounding Type (2019-2032)

• Market Overview
• Pharmaceutical Ingredient Alteration (PIA)
• Currently Unavailable Pharmaceutical Manufacturing (CUPM)
• Pharmaceutical Dosage Alteration (PDA)
• Others

Global Compounding Pharmacy Market Size By Sterility (2019-2032)

• Market Overview
• Sterile
• Non Sterile

Global Compounding Pharmacy Market Size By Age Cohort (2019-2032)

• Market Overview
• Pediatric
• Adult
• Geriatric

Global Compounding Pharmacy Market Size By Distribution Channel (2019-2032)

• Market Overview
• Online
• Offline
  • Compounding Pharmacy
  • Hospital Pharmacy
  • Others

Global Compounding Pharmacy Market Size By Region (2019-2032)

• North America (By Product Type, By Therapeutic Area, By Compounding Type, By Sterility, By Age Cohort, & By Distribution Channel)
  • US
  • Canada
• Europe (By Product Type, By Therapeutic Area, By Compounding Type, By Sterility, By Age Cohort, & By Distribution Channel)
  • UK
  • Germany
  • Spain
  • France
  • Italy
  • Rest of Europe
• Asia-Pacific (By Product Type, By Therapeutic Area, By Compounding Type, By Sterility, By Age Cohort, & By Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
• Latin America (By Product Type, By Therapeutic Area, By Compounding Type, By Sterility, By Age Cohort, & By Distribution Channel)
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa (By Product Type, By Therapeutic Area, By Compounding Type, By Sterility, By Age Cohort, & By Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Dashboard

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025

Key Company Profiles

• Becton, Dickinson and Company
  • Company Overview
  • Product Portfolio Overview
  • Financial Overview
  • Key Developments
• B. Braun Melsungen AG
• Fagron NV
• Fresenius Kabi AG
• McGuff Compounding Pharmacy Services Inc.
• Village Compounding Pharmacy
• Dougherty's Pharmacy, Inc.
• Institutional Pharmacy Solutions
• Walgreen Co.
• Triangle Compounding Pharmacy
• Custom Med Apothecary
• Olympia Pharmacy
• Precision Compounding Pharmacy
• College Pharmacy
• Rx3 Compounding Pharmacy
• Aurora Health Care
• Wedgewood Pharmacy
• Afrigen Biologics
• Albertsons Companies
• Formul8

Conclusion & Analyst Recommendations